Announcements Trials
Browse Landscape

Phase

Phase 1 5Phase 2 1

Status

Completed 4Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 2

Study Type

Interventional 5

Sponsor

Cancer Type

Gastrointestinal 12Thoracic 6Other solid neoplasm 5Head & Neck 4Tumor-Agnostic 3Sarcoma 1Genitourinary 1

Conditions

Solid Tumors 2Unspecified Adult Solid Tumor, Protocol Specific 1Solid Tumor, Adult 1Advanced Solid Tumors 1

Interventions

Cisplatin 70Paclitaxel 68pembrolizumab 65Carboplatin 61Irinotecan 59Injections 53Gemcitabine 53Docetaxel 49Fluorouracil 35Cyclophosphamide 35Pemetrexed 34Oxaliplatin 31Capecitabine 30Bevacizumab 29Leucovorin 27atezolizumab 23Nivolumab 23tislelizumab 19Etoposide 18Cetuximab 17durvalumab 16Temozolomide 16Bortezomib 16alvocidib 15Topotecan 15olaparib 14Sorafenib 14Rifampin 14Itraconazole 14Erlotinib Hydrochloride 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 1 × Panitumumab × Other solid neoplasm × Clear all
NCT04185883 2025-10-22

Sotorasib Activity in Subjects With Advanced Solid Tumors With KRAS p.G12C Mutation (CodeBreak 101)

Amgen

Phase 1 Active not recruiting
610 enrolled
Other solid neoplasmSarcoma

Advanced Solid Tumors

NCT03360734 2021-07-12

GATTO

Glycotope GmbH

Phase 1 Completed
50 enrolled
Other solid neoplasm

Solid Tumor, Adult

NCT00610948 2017-05-04

Everolimus, Fluorouracil, Leucovorin, Panitumumab, and Oxaliplatin in Treating Patients With Tumors That Did Not Respond to Treatment

UNC Lineberger Comprehensive Cancer Center

Phase 1 Completed
74 enrolled
Other solid neoplasm

Unspecified Adult Solid Tumor, Protocol Specific

NCT00658658 2016-05-18

Panitumumab in Children With Solid Tumors

Amgen

Phase 1 Completed
31 enrolled 19 charts
Other solid neoplasm

Solid Tumors

NCT00586443 2014-11-19

BEP

Duke University

Phase 1 Completed
56 enrolled
Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡